Insufficient scRNA-seq data for expression of CHRNA1 at single-cell level.
Insufficient scRNA-seq data for expression of CHRNA1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| muscle | 100% | 9304.37 | 803 / 803 | 0% | 0 | 0 / 0 |
| brain | 50% | 53.85 | 1315 / 2642 | 30% | 3.94 | 212 / 705 |
| lymph node | 0% | 0 | 0 / 0 | 59% | 1.54 | 17 / 29 |
| breast | 15% | 12.09 | 70 / 459 | 36% | 0.87 | 407 / 1118 |
| lung | 25% | 23.17 | 147 / 578 | 26% | 0.87 | 302 / 1155 |
| skin | 4% | 21.67 | 75 / 1809 | 46% | 6.70 | 216 / 472 |
| intestine | 29% | 37.55 | 280 / 966 | 19% | 0.33 | 98 / 527 |
| ovary | 1% | 0.21 | 2 / 180 | 40% | 1.92 | 170 / 430 |
| heart | 32% | 15.28 | 277 / 861 | 0% | 0 | 0 / 0 |
| stomach | 2% | 0.59 | 6 / 359 | 23% | 0.57 | 66 / 286 |
| pancreas | 2% | 0.62 | 7 / 328 | 22% | 0.46 | 40 / 178 |
| kidney | 1% | 0.20 | 1 / 89 | 22% | 0.89 | 195 / 901 |
| esophagus | 2% | 7.29 | 34 / 1445 | 20% | 0.43 | 36 / 183 |
| tonsil | 0% | 0 | 0 / 0 | 20% | 1.11 | 9 / 45 |
| adipose | 20% | 12.46 | 239 / 1204 | 0% | 0 | 0 / 0 |
| prostate | 11% | 62.05 | 26 / 245 | 8% | 0.36 | 42 / 502 |
| uterus | 1% | 0.34 | 2 / 170 | 17% | 7.30 | 80 / 459 |
| bladder | 0% | 0 | 0 / 21 | 14% | 0.42 | 71 / 504 |
| spleen | 14% | 4.76 | 33 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 11% | 18.55 | 144 / 1335 | 0% | 0 | 0 / 0 |
| thymus | 4% | 2.54 | 27 / 653 | 5% | 0.21 | 30 / 605 |
| eye | 0% | 0 | 0 / 0 | 5% | 0.12 | 4 / 80 |
| liver | 1% | 0.44 | 2 / 226 | 3% | 0.56 | 13 / 406 |
| peripheral blood | 4% | 2.74 | 37 / 929 | 0% | 0 | 0 / 0 |
| adrenal gland | 0% | 0.14 | 1 / 258 | 2% | 0.11 | 5 / 230 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0042391 | Biological process | regulation of membrane potential |
| GO_0051899 | Biological process | membrane depolarization |
| GO_0003009 | Biological process | skeletal muscle contraction |
| GO_0046716 | Biological process | muscle cell cellular homeostasis |
| GO_0060079 | Biological process | excitatory postsynaptic potential |
| GO_0034220 | Biological process | monoatomic ion transmembrane transport |
| GO_0095500 | Biological process | acetylcholine receptor signaling pathway |
| GO_0050905 | Biological process | neuromuscular process |
| GO_0007274 | Biological process | neuromuscular synaptic transmission |
| GO_0007528 | Biological process | neuromuscular junction development |
| GO_0070050 | Biological process | neuron cellular homeostasis |
| GO_0019228 | Biological process | neuronal action potential |
| GO_0035094 | Biological process | response to nicotine |
| GO_0006812 | Biological process | monoatomic cation transport |
| GO_0048630 | Biological process | skeletal muscle tissue growth |
| GO_0050881 | Biological process | musculoskeletal movement |
| GO_0007271 | Biological process | synaptic transmission, cholinergic |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0031594 | Cellular component | neuromuscular junction |
| GO_0043005 | Cellular component | neuron projection |
| GO_0009986 | Cellular component | cell surface |
| GO_0045202 | Cellular component | synapse |
| GO_0099634 | Cellular component | postsynaptic specialization membrane |
| GO_0045211 | Cellular component | postsynaptic membrane |
| GO_0005892 | Cellular component | acetylcholine-gated channel complex |
| GO_1904315 | Molecular function | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential |
| GO_0015464 | Molecular function | acetylcholine receptor activity |
| GO_0042166 | Molecular function | acetylcholine binding |
| GO_0022848 | Molecular function | acetylcholine-gated monoatomic cation-selective channel activity |
| Gene name | CHRNA1 |
| Protein name | Cholinergic receptor nicotinic alpha 1 subunit Acetylcholine receptor subunit alpha |
| Synonyms | CHNRA hCG_1811440 ACHRA |
| Description | FUNCTION: [Isoform 1]: Upon acetylcholine binding, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. .; FUNCTION: [Isoform 2]: Non functional acetylcholine receptor alpha subunit which is not integrated into functional acetylcholine-gated cation-selective channels. . FUNCTION: Upon acetylcholine binding, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. . FUNCTION: Upon acetylcholine binding, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. . |
| Accessions | G5E9G9 P02708 B8ZZD3 E7ENE5 Q53SH4 ENST00000636168.2 ENST00000409323.1 ENST00000348749.9 [P02708-2] F8WDS3 ENST00000435083.5 ENST00000672640.1 ENST00000409219.5 ENST00000409542.5 A0A1B0GV17 ENST00000261007.9 [P02708-1] |